Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Labcorp Genetics |
RCV000548770 | SCV000652479 | likely benign | Hereditary spastic paraplegia 49 | 2024-11-07 | criteria provided, single submitter | clinical testing | |
Baylor Genetics | RCV000548770 | SCV001522278 | uncertain significance | Hereditary spastic paraplegia 49 | 2019-05-15 | criteria provided, single submitter | clinical testing | This variant was determined to be of uncertain significance according to ACMG Guidelines, 2015 [PMID:25741868]. |
Gene |
RCV004777733 | SCV005388035 | uncertain significance | not provided | 2024-03-26 | criteria provided, single submitter | clinical testing | In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Has not been previously published as pathogenic or benign to our knowledge |
Prevention |
RCV003915605 | SCV004733954 | likely benign | TECPR2-related disorder | 2022-03-28 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |